2-100284411-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_198461.4(LONRF2):c.2152G>A(p.Gly718Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000168 in 1,605,642 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_198461.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LONRF2 | NM_198461.4 | c.2152G>A | p.Gly718Ser | missense_variant | 12/12 | ENST00000393437.8 | NP_940863.3 | |
LONRF2 | NM_001371783.1 | c.1423G>A | p.Gly475Ser | missense_variant | 13/13 | NP_001358712.1 | ||
LONRF2 | XM_047443537.1 | c.1423G>A | p.Gly475Ser | missense_variant | 12/12 | XP_047299493.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152216Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000853 AC: 2AN: 234438Hom.: 0 AF XY: 0.0000158 AC XY: 2AN XY: 126808
GnomAD4 exome AF: 0.0000165 AC: 24AN: 1453426Hom.: 0 Cov.: 30 AF XY: 0.0000152 AC XY: 11AN XY: 721966
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152216Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74362
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 01, 2024 | The c.2152G>A (p.G718S) alteration is located in exon 12 (coding exon 12) of the LONRF2 gene. This alteration results from a G to A substitution at nucleotide position 2152, causing the glycine (G) at amino acid position 718 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at